77
Views
38
CrossRef citations to date
0
Altmetric
Original Articles

Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs

, , &
Pages 581-593 | Published online: 18 Jul 2013

References

  • Albanis, E., Safadi, R. & Friedman, S. L. (2003). Treatment of hepatic fibrosis: almost there. Current Gastroenterology Reports, 5, 48-56.
  • Amiri, P., Locksley, R. M., Parslow, T. G., Sadick, M., Rector, E., Ritter, D. & McKerrow, J. H. (1992). Tumor necrosis factor a restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature, 356,604–607.
  • Arthur, M. J. (2000). Fibrogenesis II. Metallo-proteinases and their inhibitors in liver fibrosis. American Journal of Physiology. Gastrointestinal and Liver Physiology, 279, G245—G249.
  • Bergman, I. & Loxley, R. (1963). Two improved and simplified methods for the spectrophotometric deter-mination of hydroxyproline. Analytical Chemistry, 35, 1961–1965 .
  • Biempica, L., Dunn, M. A., Kamel, I. A., Kamel, R., Hait, P. K., Fleischner, C., Biempica, S. L., Wu, C. H. & Rojkind, M. (1983a). Liver collagen-type characterization in human schistosomiasis. A histo-logical, ultrastructural and immunocytochemical correlation. American Journal of Tropical Medicine and Hygiene, 32,316–325.
  • Biempica, L., Takahashi, S., Biempica, S. & Kobayashi, M. (1983b). Immunohistochemical localization of collagenase in hepatic murine schistosomiasis. Journal of Histochemistry and Cytochemistry, 31, 488–494.
  • Boros, D. L. & Warren, K. S. (1970). Delayed hyper-sensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. Journal of Experimental Medicine, 132,488–507.
  • Brew, K., Dinakarpandian, D. & Nagase, H. (2000). Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta, 1477,267–283.
  • Brunet, L. R., Finkelman, F. D., Cheever, A. W., Kopf, M. A. & Pearce, E. J. (1997). IL-4 protects against TNF-a-mediated cachexia and death during acute schistosomiasis. Journal of Immunology, 159, 777–785.
  • Brunet, L. R., Beall, M., Dunne, D. W. & Pearce, E. J. (1999). Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection. Journal of Immunology, 163, 4976–4984.
  • Cheever, A. W., Duvall, R. H., Hallack Jr, T. A., Minker, R. G., Malley, J. D. & Malley, K. G.(1987). Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 37, 85-97.
  • Cheever, A. W., Williams, M. E., Wynn, T. A., Finkelman, F. D., Seder, R. A., Cox, T. M., Hieny, S., Caspar, P. & Sher, A. (1994). Anti IL-4 treatment of Schistosoma mansoni-infected mice inhibits develop-ment of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. Journal of Immunology, 153,753–759.
  • Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W. & Wynn, T. A. (1999). An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. Journal of Clinical Investigation, 104, 777–785.
  • Cutroneo, K. R. & Boros, D. L. (2002). Rational basis for oligodeoxynucleotides to inhibit collagen synthesis in lung fibroblasts and primary fibroblasts from liver granulomas of Schistosoma mansoni-infected mice. Cancer Letters, 180, 145–151.
  • Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M.-A., Wind, R., Biempica, L. & Zem, M. A. (1989a). In vitro and in vivo association of transforming growth factor-I31 with hepatic fibrosis. Journal of Cell Biology, 108, 2477–2482.
  • Czaja, M. J., Weiner, F. R., Takahashi, S., Giambrone, M. A., Vander Meide, P. H., Schellekens, H., Biempica, L. & Zem, M. A. (1989b). 7-Interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology, 10, 795–800.
  • Dunne, M. A., Rojkind, M., Warren, K. S., Hait, P. K., Rifas, L. & Seifter, S. (1977). Liver collagen synthesis in murine schistosomiasis. Journal of Clinical Investigation, 59, 666–674.
  • Dunne, M. A., Kamel, R., Kamel, I. A., Biempica, L., Kholy, A. E., Hait, P. K., Rojkind, M., Warren, K. S. & Mahmoud, A. A. (1979). Liver collagen synthesis in schistosomiasis mansoni. Gastroenterology, 76, 978–982.
  • El Meneza, S., Olds, G. R., Kresina, T. F. & Mahmoud, A. A. F. (1989). Dynamics of hepatic connective tissue matrix constituents during murine Schistosoma mansoni infection. Hepatology, 9,50–56.
  • Fallon, P. G., Richardson, E. J., McKenzie, G. J. & McKenzie, A. N. (2000). Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. Journal of Immunology, 164, 2585–2591.
  • Ferrini, M. G., Vernet, D., Magee, T. R., Shahed, A., Qian, A., Rajfer, J. & Gonzalez-Cadavid, N. F. (2002). Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide, 6,283–294.
  • Gerard, H. C., Wang, Z., Whittum-Hudson, J. A., El Gabalawy, H., Goldbach-Mansky, R., Bardin, T., Schumacher, H. R. & Hudson, A. P. (2002). Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. Journal of Rheuma-tology, 29, 1827–1835 .
  • Gomez, D. E., de Lorenzo, M. S., Alonso, D. F. & Andrade, Z. A. (1999). Expression of metallo-proteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistoso-mal portal fibrosis. American Journal of Tropical Medicine and Hygiene, 61, 9–13.
  • Grimaud, J. A., Boros, D. L., Takiya, C., Mathew, R. C. & Emonard, H. (1987). Collagen isotypes, laminin and fibronectin in granulomas of the liver and intestines of Schistosoma mansoni-infected mice. American Journal of Tropical Medicine and Hygiene, 37, 335–344.
  • Henri, S., Chevillard, C., Mergani, A., Paris, P., Gaudart, J., Camilla, C., Dessein, H., Montero, F., Elwali, N. E., Saeed, O. K., Magzoub, M. & Dessein, A. J. (2002). Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-y is associated with protection against fibrosis and TNF-CL with aggravation of disease. Journal of Immunology, 169, 929–936.
  • Hesse, M., Cheever, A. W., Jankovic, D. & Wynn, T. A. (2000). N0S-2 mediates the protective anti-inflammatory and antifibrotic effects of the Thl -inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. American Journal of Pathology, 157,945–955.
  • Joseph, A. L. & Boros, D. L. (1993). Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. Journal of Immunology, 151, 5461–5471.
  • Kresina, T. F., He, Q., Degli Esposti, S. & Zem, M. A. (1994). Gene expression of transforming growth factor 131 and extracellular matrix proteins in murine Schistosoma mansoni infection. Gastroenterology, 107, 773–780.
  • Loeffler, D. A., Lundy, S. K., Singh, K. P., Gerard, H. C., Hudson, A. P. & Boros, D. L. (2002). Soluble egg antigens from Schistosoma mansoni induce angio-genesis-related processes by upregulating vascular endothelial growth factor in human endothelial cells. Journal of Infectious Diseases, 185, 1650–1656.
  • McCrudden, R. & Iredale, J. P. (2000). Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histology and Histopathology, 15, 1159–1168.
  • Mwatha, J. K., Kimani, G., Kamau, T., Mbugua, G. G., Ouma, J. H., Mumo, J., Fulford, A. J., Jones, F. M., Butterworth, A. E., Roberts, M. B. & Dunne, D. W. (1998). High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-7, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. Journal of Immunology, 160, 1992–1999.
  • Nagase, H. & Woessner Jr, J. F. (1999). Matrix metalloproteinases. Journal of Biological Chemistry, 274,21,491-21,494.
  • Ragheb, S., Mathew, R. C. & Boros, D. L. (1987). Establishment and characterization of an antigen-specific T cell line from liver granulomas of Schisto-soma mansoni-infected mice. Infection and Immunity, 55,2625–2630.
  • Reddy, G. K. & Envenemeka, C. S. (1996). A simplified method for the analysis of hydroxyproline in biologi-cal tissues. Clinical Biochemistry, 29, 225–229.
  • Ricard-Blum, S., Ville, G. & Grimaud, J. A. (1992). Pyridinoline, a mature collagen cross-link in fibrotic livers from Schistosoma mansoni-infected mice. American Journal of Tropical Medicine and Hygiene, 47, 816–820 .
  • Singh, K. P., Gerard, H. C., Hudson, A. P. & Boros, D. L. (2004). Expression of matrix metallopro-teinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology, 111, 343–352.
  • Takahashi, S. & Simpser, E. (1981). Granuloma collagenase and EDTA-sensitive neutral protease production in hepatic murine schistosomiasis. Hepatology, 1,211–220.
  • Takahashi, S., Dunn, M. A. & Seifter, S. (1980). Liver collagenase in murine schistosomiasis. Gastroenterology, 78, 1425-1431.
  • Truden, J. L. & Boros, D. L. (1985). Collagenase, elastase and nonspecific protease production by vigorous or immunomodulated liver granulomas and macrophages/eosinophils of S. mansoni-infected mice. American Journal of Pathology, 121,166–175.
  • Vaillant, B., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D. & Wynn, T. A. (2001). Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. Journal of Immunology, 167,7017–7026.
  • Weinstock, J. V. (1992). The pathogenesis of granulo-matous inflammation and organ injury in schistoso-miasis: interactions between schistosome ova and the host. Immunological Investigations, 21, 455–475.
  • World Health Organization (1993). Public health impact of schistosomiasis: disease and mortality. Bulletin of the World Health Organization, 71,657–662.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.